Sponsors (2)
The bill expands predictable federal funding for diabetes prevention — improving access and enabling multi-year planning — at the cost of new federal spending and potential risks from appropriations uncertainty and reduced budget flexibility.
People at risk for type 2 diabetes (especially low-income individuals) will get expanded, predictable federal funding for evidence-based prevention programs — $39.3M–$59.3M annually from FY2027–FY2031 — improving access to prevention services.
Local health departments, community providers, and hospitals can plan and sustain multi-year diabetes prevention services because the bill authorizes fixed funding levels, improving program continuity and administrative planning.
Stable federal authorizations increase the likelihood programs will reach more people and operate continuously, which may lower future type 2 diabetes incidence and reduce downstream medical costs for patients and taxpayers.
Authorized funding does not guarantee appropriations — if Congress does not actually appropriate the money, hospitals, local health departments, and community providers could face program disruptions despite the authorization.
Taxpayers will face increased federal spending commitments of about $246.5 million total across FY2027–FY2031 to support the program at the authorized levels.
Prescribing set funding levels reduces budgetary flexibility and could limit the ability to reallocate funds to other emerging public health priorities if needs change.
Based on analysis of 2 sections of legislative text.
Sets fixed annual authorized funding for the National Diabetes Prevention Program for FY2027–FY2031 ($39.3M to $59.3M per year).
Official title: To reauthorize the National Diabetes Prevention Program.
Introduced August 13, 2026 by Monica De La Cruz · Last progress August 13, 2026
Provides specific annual authorized funding levels for the National Diabetes Prevention Program for fiscal years 2027 through 2031, replacing a prior open-ended authorization that covered 2010–2014. It sets dollar amounts for each year ($39.3M in FY2027 up to $59.3M in FY2031) but does not itself appropriate funds. The change updates the statute that governs the Program by fixing yearly authorization amounts; actual spending continues to require separate appropriations actions by Congress.